Vimarsana
Biggest News Aggregation in the World

Page 11 - Registration Statements News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Registration Statements. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Registration Statements Today - Breaking & Trending Today

GoldMining : EQUITY DISTRIBUTION AGREEMENT - Form 6-K -November 30, 2023 at 06:04 am EST - Vimarsana News

GoldMining : EQUITY DISTRIBUTION AGREEMENT - Form 6-K -November 30, 2023 at 06:04 am EST

EQUITY DISTRIBUTION AGREEMENT November 24, 2023 BMO Nesbitt Burns Inc.‎ ‎885 West Georgia Street, Suite...

Taboola Announces New, Five-Year Deal with NBCUniversal News Group, Including NBC News, CNBC, ... - Vimarsana News

Taboola Announces New, Five-Year Deal with NBCUniversal News Group, Including NBC News, CNBC, ...

NEW YORK, Nov. 28, 2023 (GLOBE NEWSWIRE) -- Taboola (Nasdaq: TBLA), a global leader in powering recommendations for the open web, today announced a new five-year deal with NBCUniversal News

Can Fite BioPharma : Report Of Foreign Private Issuer - Form 6-K -November 22, 2023 at 04:18 pm EST - Vimarsana News

Can Fite BioPharma : Report Of Foreign Private Issuer - Form 6-K -November 22, 2023 at 04:18 pm EST

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K Report of Foreign Private Issuer ...

Purple Biotech Reports Third Quarter 2023 Financial - Vimarsana News

Purple Biotech Reports Third Quarter 2023 Financial

Initial Activity in Head and Neck Cancer Demonstrated in NT219 Phase 1/2 Dose Escalation Study Patients’ Enrollment in the Phase 2 Randomized CM24...

Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform and Updates Anticipated Clinical Milestones - Vimarsana News

Calidi Biotherapeutics Announces Issuance of New U.S. Patent Covering Novel SuperNova Technology Platform and Updates Anticipated Clinical Milestones

Calidi Biotherapeutics, Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the issuance of a new patent for the company’s...